For this purpose, we used our LUMC produced proteomics data, and after batch correction (Fig. S6A, S6B, see Methods) for matched AML cases (n = 39; LUMC) to correlate the abundance of Apoptosis regulator BCL-2 protein vs gene expression (Fig. S6C) and CD14+ Monocyte percentages (Fig. S6D). The gene discussed is BCL2; the disease is acute myeloid leukemia.